Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails

被引:41
作者
Kraut-Becher, JR
Gift, TL
Haddix, AC
Irwin, KL
Greifinger, RB
机构
[1] Univ Penn, Ctr Studies Addict, Philadelphia, PA 19104 USA
[2] Swarthmore Coll, Dept Econ, Swarthmore, PA 19081 USA
[3] Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA
[4] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
来源
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE | 2004年 / 81卷 / 03期
关键词
chlamydia; cost-effectiveness analysis; gonorrhea; jails; screening;
D O I
10.1093/jurban/jth130
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Universal screening for the sexually transmitted diseases (STDs) of chlamydia and gonorrhea on intake in jails has been proposed as the most effective strategy to decrease morbidity in inmates and to reduce transmission risk in communities after release. Most inmates come from a population that is at elevated risk for STDs and has limited access to health care. However, limited resources and competing priorities force decision makers to consider the cost of screening programs in comparison to other needs. The costs and cost-effectiveness of universal screening in correctional settings have not been documented. We estimated the incremental cost-effectiveness of universal urine-based screening for chlamydia and gonorrhea among inmates on intake in US jails compared to the commonly used practice of presumptive treatment of symptomatic inmates without laboratory testing. Decision analysis models were developed to estimate the costeffectiveness of screening alternatives and were applied to hypothetical cohorts of male and female inmates. For women, universal screening for chlamydia only was cost-saving to the health care system, averting more health care costs than were incurred in screening and treatment. However, for men universal chlamydia screening cost $4,856 more per case treated than presumptive treatment. Universal screening for both chlamydia and gonorrhea infection cost the health care system $3,690 more per case of pelvic inflammatory disease averted for women and $650 more per case of infection treated for men compared to universal screening for chlamydia only. jails with a high prevalence of chlamydia and gonorrhea represent an operationally feasible and cost-effective setting to universally test and treat women at high risk for STDs and with limited access to care elsewhere.
引用
收藏
页码:453 / 471
页数:19
相关论文
共 78 条
[11]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1041
[12]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1
[13]  
centers for Disease Control Prevention, 2002, MMWR Morb Mortal Wkly Rep, V51, P32
[14]  
Chesson HW, 2000, J ACQ IMMUN DEF SYND, V24, P48
[15]   THE POTENTIAL ROLE OF CUSTODY FACILITIES IN CONTROLLING SEXUALLY-TRANSMITTED DISEASES [J].
COHEN, D ;
SCRIBNER, R ;
CLARK, J ;
CORY, D .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (04) :552-556
[16]  
Conklin TJ, 1998, AM J PUBLIC HEALTH, V88, P1249
[17]   Self-reported health and prior health behaviors of newly admitted correctional inmates [J].
Conklin, TJ ;
Lincoln, T ;
Tuthill, RW .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (12) :1939-1941
[18]   Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection [J].
Dean, D ;
Ferrero, D ;
McCarthy, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (01) :94-99
[19]   Gonorrhea prevalence and coinfection with chlamydia in women in the United States, 2000 [J].
Dicker, LW ;
Mosure, DJ ;
Berman, SM ;
Levine, WC .
SEXUALLY TRANSMITTED DISEASES, 2003, 30 (05) :472-476
[20]  
*DIV STD PREV, 2001, SEX TRANSM DIS SURV